(Q43115455)

14 November 2017

title

Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence (English)

1 reference

acute myocardial infarction

14 November 2017

main subject

1 reference

Timm Bauer

1

1 reference

14 November 2017

Anselm K Gitt

2

1 reference

14 November 2017

Claus Jünger

3

1 reference

14 November 2017

Ralf Zahn

4

1 reference

14 November 2017

Oliver Koeth

5

1 reference

14 November 2017

Frank Towae

6

1 reference

14 November 2017

Arne K Schwarz

7

1 reference

14 November 2017

Kurt Bestehorn

8

1 reference

14 November 2017

Jochen Senges

9

1 reference

14 November 2017

Uwe Zeymer

10

1 reference

14 November 2017

Acute Coronary Syndromes Registry (ACOS) investigators

11

1 reference

14 November 2017

language of work or name

1 reference

1 October 2010

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

14 November 2017

published in

1 reference

14 November 2017

volume

17

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

576-581

1 reference

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Expert consensus document on beta-adrenergic receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Medication adherence after myocardial infarction: a long way left to go.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) ini

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Management of peripheral arterial disease of the lower extremities in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Efficacy and safety of benazepril for advanced chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338E5DA

10.1097/HJR.0B013E328338E5DA

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference